Remove 2022 Remove Competition Remove Leads
article thumbnail

FTC order could ease biopharma competition

European Pharmaceutical Review

to address the potential competitive harm Amgen’s $27.8 Consolidation in the pharmaceutical industry has given companies the power and incentive to engage in exclusionary rebating practices, which can lead to sky-rocketing prices on essential medications,” stated Henry Liu, Director of the FTC’s Bureau of Competition.

article thumbnail

Moderna’s Covid-19 vaccine sales forecast slashed amidst strong competition

Pharmaceutical Technology

It was an exceptional year for Moderna’s vaccine Spikevax, with forecast sales of $19.5bn in 2022. Currently, Spikevax is the second bestselling Covid-19 vaccine behind Pfizer’s Comirnaty, which is in the leading position, with forecast sales of $37bn in 2022.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

UnitedHealth-Walmart partnership heats up U.S. Medicare provider competition

Clarivate

The plans are profitable and continue to draw new Medicare enrollees, leading all top payers to make investments in retaining and attracting enrollees. Teaming with Walmart allows UnitedHealth to keep its leading position in the Medicare Advantage segment, where it holds the top market share with 7.9 2 Humana by more than 2.5

article thumbnail

2022 spells change for EU pharmaceutical legislation

European Pharmaceutical Review

2022 is probably the biggest year in EU pharmaceutical law that I have seen in 30 years. 2022 is undeniably a critical year for change in the pharmaceutical industry: for the first time in several decades, the European Union (EU)’s pharmaceutical legislation is up for review. Key areas of potential legislative change. Future outlook.

article thumbnail

H2 2022 to see the decline of Covid-19 vaccines as forecasts decrease

Pharmaceutical Technology

According to GlobalData’s Drugs database, there were 22 prophylactic vaccines in development for COVID-19 with sales forecasts available in H2 2022. According to GlobalData’s Drugs database, there were 22 prophylactic vaccines in development for COVID-19 with sales forecasts available in H2 2022.

Sales 52
article thumbnail

2022 Sales Hiring Forecast

Sales Talent

Although none of these resources give a sales-specific hiring forecast, there is enough information between them to accurately predict sales hiring for 2022. Our prior sales forecast for 2021 predicted that “competition for talent should become intense in the latter half of 2021.” 2022 Sales Forecast for Hiring.

Sales 52
article thumbnail

Do healthcare mergers and acquisitions lead to better care for patients?

Clarify Health

But consolidation in healthcare markets is not with its critics, with some experts raising concerns over increasing prices due to decreased competition and eliminating services. A Health Affairs study from 2022 also found that private equity acquisitions drove higher operating margins and decreased discharge costs.

Leads 52